BindingDB logo
myBDB logout

null

SMILES: C\C=C\C(=O)N(C)c1cccc(c1)-c1ccc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O

InChI Key: InChIKey=IELBEIPVEXKBJL-FNORWQNLSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 450411   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase BTK


(Homo sapiens (Human))
BDBM450411
PNG
(US10676434, Example 37)
Show SMILES C\C=C\C(=O)N(C)c1cccc(c1)-c1ccc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O
Show InChI InChI=1S/C27H27N3O3/c1-5-7-23(31)30(4)18-9-6-8-16(14-18)19-12-13-21(26(28)32)25-24(19)20-11-10-17(27(2,3)33)15-22(20)29-25/h5-15,29,33H,1-4H3,(H2,28,32)/b7-5+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.160n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
A test compound was incubated with human recombinant Btk (100 nM) for 1.5 h at a concentration of 25 times the IC50 of Btk inhibition or 200 nM (whic...


US Patent US10676434 (2020)


BindingDB Entry DOI: 10.7270/Q2CN76Z8
More data for this
Ligand-Target Pair
Tyrosine-protein kinase BTK


(Homo sapiens (Human))
BDBM450411
PNG
(US10676434, Example 37)
Show SMILES C\C=C\C(=O)N(C)c1cccc(c1)-c1ccc(C(N)=O)c2[nH]c3cc(ccc3c12)C(C)(C)O
Show InChI InChI=1S/C27H27N3O3/c1-5-7-23(31)30(4)18-9-6-8-16(14-18)19-12-13-21(26(28)32)25-24(19)20-11-10-17(27(2,3)33)15-22(20)29-25/h5-15,29,33H,1-4H3,(H2,28,32)/b7-5+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.160n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
To V-bottom 384-well plates were added test compounds, human recombinant Btk (1 nM, Invitrogen Corporation), fluoresceinated peptide (1.5 μM), A...


US Patent US10676434 (2020)


BindingDB Entry DOI: 10.7270/Q2CN76Z8
More data for this
Ligand-Target Pair